XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in XBiotech Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +1 vs. Q3 2023
- Shares held
- 3.45M
- +105.6K (+3.2%) vs. Q3 2023
- Total value
- $13.8M
- −$192.5K (−1.4%) vs. Q3 2023
- New holders
- 4
- 14 more added
- Sold out
- 3
- 8 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $4.56M |
| Q1 2026 | 37 | $4.68M |
| Q4 2025 | 41 | $5.48M |
| Q3 2025 | 48 | $7.81M |
| Q2 2025 | 53 | $10.1M |
| Q1 2025 | 55 | $14.5M |
| Q4 2024 | 53 | $18.6M |
| Q3 2024 | 50 | $37.5M |
| Q2 2024 | 46 | $23.2M |
| Q1 2024 | 46 | $32.5M |
| Q4 2023 | 39 | $13.8M |
| Q3 2023 | 38 | $14.0M |
| Q2 2023 | 39 | $20.7M |
| Q1 2023 | 39 | $8.61M |
| Q4 2022 | 41 | $9.68M |
| Q3 2022 | 45 | $11.1M |
| Q2 2022 | 56 | $18.9M |
| Q1 2022 | 64 | $34.9M |
| Q4 2021 | 61 | $46.8M |
| Q3 2021 | 66 | $56.7M |
| Q2 2021 | 56 | $66.8M |
| Q1 2021 | 65 | $74.1M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding XBiotech Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 881,511 | $3.53M | 0.00% | +9,068+1.0% | Added |
| Millennium Management LLC | 795,726 | $3.18M | 0.00% | −135,718−14.6% | Reduced |
| BlackRock Inc. | 278,159 | $1.11M | 0.00% | −676−0.2% | Reduced |
| Credit Suisse AG | 248,270 | $993.1K | 0.00% | +3,000+1.2% | Added |
| Geode Capital Management, LLC | 192,588 | $770.5K | 0.00% | +9,850+5.4% | Added |
| Bridgeway Capital Management, LLC | 144,593 | $578.4K | 0.01% | +5,352+3.8% | Added |
| Morgan Stanley | 110,517 | $442.1K | 0.00% | +23,290+26.7% | Added |
| Northern Trust Corp | 79,027 | $316.1K | 0.00% | +26,279+49.8% | Added |
| Dimensional Fund Advisors LP | 72,475 | $289.8K | 0.00% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 63,945 | $255.8K | 0.00% | −373−0.6% | Reduced |
| Empowered Funds, LLC | 59,552 | $238.2K | 0.01% | +5,352+9.9% | Added |
| Man Group plc | 58,355 | $233.4K | 0.00% | – | – |
| State Street Corp | 56,526 | $226.1K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 56,477 | $225.9K | 0.00% | +53,917+2,106.1% | Added |
| Bank of New York Mellon Corp | 55,693 | $222.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 37,446 | $149.8K | 0.00% | −3,583−8.7% | Reduced |
| National Bank of Canada | 24,347 | $103.2K | 0.00% | +24,347 | New |
| Two Sigma Investments, LP | 25,440 | $101.8K | 0.00% | −5,400−17.5% | Reduced |
| Two Sigma Advisers, LP | 24,000 | $96.0K | 0.00% | −5,200−17.8% | Reduced |
| FMR LLC | 20,040 | $80.2K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 18,922 | $75.7K | 0.00% | +18,922 | New |
| Price T Rowe Associates Inc | 17,600 | $71.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 16,327 | $65.3K | 0.00% | +16,327 | New |
| Citigroup Inc | 14,739 | $59.0K | 0.00% | +14,337+3,566.4% | Added |
| Bank of America Corp | 13,358 | $53.4K | 0.00% | −397−2.9% | Reduced |
| Thomasville National Bank | 13,350 | $53.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,274 | $49.1K | 0.00% | +1,621+15.2% | Added |
| Synovus Financial Corp | 11,796 | $47.2K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 11,322 | $45.3K | 0.00% | +500+4.6% | Added |
| Charles Schwab Investment Management Inc | 10,477 | $41.9K | 0.00% | 00.0% | Unchanged |
| LGT Fund Management Co Ltd. | 10,000 | $39.7K | 0.02% | 00.0% | Unchanged |
| UBS Group AG | 9,449 | $37.8K | 0.00% | +4,172+79.1% | Added |
| Rhumbline Advisers | 753 | $3.01K | 0.00% | 00.0% | Unchanged |
| McIlrath & Eck, LLC | 753 | $3.01K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 626 | $2.00K | 0.00% | +462+281.7% | Added |
| Royal Bank of Canada | 288 | $1.00K | 0.00% | −1,147−79.9% | Reduced |
| Wells Fargo & Company | 152 | $608 | 0.00% | +8+5.6% | Added |
| Tower Research Capital LLC (TRC) | 52 | $208 | 0.00% | +52 | New |
| JPMorgan Chase & Co | 38 | $152 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −15,287−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,738−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |